4.0 Article

Comparison of estimates of central systolic blood pressure and peripheral augmentation index obtained from the Omron HEM-9000AI and SphygmoCor systems

Journal

ARTERY RESEARCH
Volume 3, Issue 1, Pages 24-31

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.artres.2009.02.001

Keywords

Applanation tonometry; Central systolic pressure; Augmentation index

Ask authors/readers for more resources

Central blood pressure is increasingly considered to be more predictive of cardiovascular events than peripheral pressure. Central systolic pressure (cSBP) can be estimated from the late systolic shoulder (pSBP2) of the radial pulse waveform. The Omron HEM-9000AI utilizes this technique to non-invasively measure cSBP through semi-automated applanation tonometry. The aim of this study was to compare the Omron HEM-9000AI with an existing device, the SphygmoCor, and to test its reproducibility. 33 subjects were tested using both the Omron and the SphygmoCor devices, which identify pSBP2 in the radial waveform, and estimate cSBP and peripheral augmentation index (pAIx) using their inbuilt software. 10 subjects were retested after a period of 24 h to determine reproducibility. There was a strong correlation (r = 0.94; P < 0.001), and no difference between mean values of pSBP2 (0.8 +/- 4.8 mmHg; P = 0.4) measured by the two devices. However estimates of cSBP were significantly higher in the Omron than the SphygmoCor (12.2 +/- 4.6 mmHg; P < 0.001), despite significant correlation (r = 0.95; P < 0.001). pAIx measurements were correlated (r = 0.85; P < 0.001) with no significant difference between absolute values (mean difference = 1 +/- 9.2%; P = 0.6). Results from both devices were reproducible, with significant correlation and insignificant mean differences for values of cSBP and pAIx. pSBP2 values were highly correlated, but a direct analysis with invasive measurements is necessary to determine which estimate of cSBP is most accurate. Excluding this discrepancy, the Omron system is potentially useful for measuring pSBP2 and pAIx in large scale trials. (C) 2009 Association for Research into Arterial Structure and Physiology. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Peripheral Vascular Disease

The Role of the Autonomic Nervous System in the Regulation of Aortic Stiffness

Kaisa M. Maki-Petaja, Sharon M. L. Barrett, Sarah V. Evans, Joseph Cheriyan, Carmel M. McEniery, Ian B. Wilkinson

HYPERTENSION (2016)

Article Peripheral Vascular Disease

Mechanisms underlying elevated SBP differ with adiposity in young adults: the Enigma study

Jessica E. Middlemiss, Karen L. Miles, Barry J. McDonnell, Yasmin, Kaisa M. Maki-Petaja, John R. Cockcroft, Ian B. Wilkinson, Carmel M. McEniery

JOURNAL OF HYPERTENSION (2016)

Article Peripheral Vascular Disease

Novel Mechanism for Buffering Dietary Salt in Humans Effects of Salt Loading on Skin Sodium, Vascular Endothelial Growth Factor C, and Blood Pressure

Viknesh Selvarajah, Kaisa M. Maki-Petaja, Liliana Pedro, Sylvaine F. A. Bruggraber, Keith Burling, Anna K. Goodhart, Morris J. Brown, Carmel M. McEniery, Ian B. Wilkinson

HYPERTENSION (2017)

Review Peripheral Vascular Disease

About That Sex-Related Stiffening

Kaisa M. Maki-Petaja, Ian B. Wilkinson

AMERICAN JOURNAL OF HYPERTENSION (2018)

Article Peripheral Vascular Disease

Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study

Marie Fisk, Carmel M. McEniery, Nichola Gale, Kaisa Maki-Petaja, Julia R. Forman, Margaret Munnery, Jean Woodcock-Smith, Joseph Cheriyan, Divya Mohan, Jonathan Fuld, Ruth Tal-Singer, Michael I. Polkey, John R. Cockcroft, Ian B. Wilkinson

HYPERTENSION (2018)

Article Multidisciplinary Sciences

The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo controlled trial

Marie Fisk, Joseph Cheriyan, Divya Mohan, Julia Forman, Kaisa M. Maki-Petaja, Carmel M. McEniery, Jonathan Fuld, James H. F. Rudd, Nicholas S. Hopkinson, David A. Lomas, John R. Cockcrote, Ruth Tal-Singer, Michael I. Polkey, Ian B. Wilkinson

PLOS ONE (2018)

Editorial Material Peripheral Vascular Disease

Backward in Coming Forward

Kaisa M. Maki-Petaja, Ian B. Wilkinson

AMERICAN JOURNAL OF HYPERTENSION (2019)

Article Peripheral Vascular Disease

Cardiovascular Phenotype of Elevated Blood Pressure Differs Markedly Between Young Males and Females: The Enigma Study

Chiara Nardin, Kaisa M. Maki-Petaja, Karen L. Miles, Yasmin, Barry J. McDonnell, John R. Cockcroft, Ian B. Wilkinson, Carmel M. McEniery

HYPERTENSION (2018)

Article Peripheral Vascular Disease

Evaluation of inert gas rebreathing for determination of cardiac output: influence of age, gender and body size

Jessica E. Middlemiss, Alex Cocks, Kaido Paapstel, Kaisa M. Maki-Petaja, Sunita, Ian B. Wilkinson, Carmel M. McEniery, Samantha Benedict, John Cockcroft, Alex Cocks, Zahid Dhakam, Lisa Day, Stacey Hickson, Kaisa Maki-Petaja, Barry McDonnell, Carmel McEniery, Jessica Middlemiss, Karen Miles, Maggie Munnery, Pawan Pusalkar, Christopher Retallick, Ramsey Sabit, Jane Smith, Jean Woodcock-Smith, Edna Thomas, Sharon Wallace, Ian Wilkinson, Yasmin

HYPERTENSION RESEARCH (2019)

Review Hematology

Uses of Arterial Stiffness in Clinical Practice

Ian B. Wilkinson, Kaisa M. Maki-Petaja, Gary F. Mitchell

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Role of Vascular Adaptation in Determining Systolic Blood Pressure in Young Adults

Shikai Yu, Jessica E. Middlemiss, Chiara Nardin, Stacey S. Hickson, Karen L. Miles, Yasmin, Kaisa M. Maki-Petaja, Barry J. McDonnell, John R. Cockcroft, Ian B. Wilkinson, Carmel M. McEniery

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Peripheral Vascular Disease

Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society

Luca Zanoli, Marie Briet, Jean P. Empana, Pedro G. Cunha, Kaisa M. Maki-Petaja, Athanase D. Protogerou, Alain Tedgui, Rhian M. Touyz, Ernesto L. Schiffrin, Bart Spronck, Philippe Bouchard, Charalambos Vlachopoulos, Rosa M. Bruno, Pierre Boutouyrie

JOURNAL OF HYPERTENSION (2020)

Article Medicine, General & Internal

Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study

Jilles M. Fermont, Marie Fisk, Charlotte E. Bolton, William MacNee, John R. Cockcroft, Jonathan Fuld, Joseph Cheriyan, Divya Mohan, Kaisa M. Maki-Petaja, Ali B. Al-Hadithi, Ruth Tal-Singer, Hana Mullerova, Michael Polkey, Angela M. Wood, Carmel M. McEniery, Ian B. Wilkinson

BMJ OPEN (2020)

Article Peripheral Vascular Disease

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension The HYPAZ Trial

Kaisa M. Maki-Petaja, Adam McGeoch, Lucy L. Yang, Annette Hubsch, Carmel M. McEniery, Paul A. R. Meyer, Fraz Mir, Parag Gajendragadkar, Nicola Ramenatte, Gayathri Anandappa, Sara Santos Franco, Simon J. Bond, Carola-Bibiane Schonlieb, Yoeri Boink, Christoph Brune, Ian B. Wilkinson, Duncan Jodrell, Joseph Cheriyan

Summary: The study found that in patients receiving the VEGF inhibitor pazopanib, the drug led to hypertension, possibly through increasing peripheral vascular resistance and reducing microvascular density and diameter.

HYPERTENSION (2021)

No Data Available